Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GPT HealthcareNSE:GPTHEALTH -0.81%44 Return-on-Tangible-Equity is 21.66% as of Mar. 2026, which is 5% below its 10-year median of 22.82. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 44/100. The stock has 3 warning signs investors should review. Among 580 Healthcare Providers & Services companies, GPT Healthcare ranks better than 62.59% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. GPT Healthcare's annualized net income for the quarter that ended in Mar. 2026 was ₹583 Mil. GPT Healthcare's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹2,689 Mil. Therefore, GPT Healthcare's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 21.66%.
The historical rank and industry rank for GPT Healthcare's Return-on-Tangible-Equity or its related term are showing as below:
NSE:GPTHEALTH'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 15.76 Med: 22.82 Max: 28.54
Current: 16.47
During the past 6 years, GPT Healthcare's highest Return-on-Tangible-Equity was 28.54%. The lowest was 15.76%. And the median was 22.82%.
NSE:GPTHEALTH's Return-on-Tangible-Equity is ranked better than 62.59% of 580
companies
in the Healthcare Providers & Services industry
Industry Median: 10.085
vs NSE:GPTHEALTH: 16.47
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
GPT Healthcare Return-on-Tangible-Equity Related Terms
GPT Healthcare Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for GPT Healthcare's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GPTHEALTH vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, GPT Healthcare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GPT Healthcare Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GPT Healthcare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where GPT Healthcare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 21.66% mean?
GPT Healthcare (NSE:GPTHEALTH) has a Return-on-Tangible-Equity of 21.66% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on GPT Healthcare and its competitors. This is near median its historical median of 22.82. Over the past decade, GPT Healthcare's Return-on-Tangible-Equity has ranged from 15.76 to 28.54. According to the industry distribution chart, GPT Healthcare ranks #217 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 37.4%.
Is GPT Healthcare's Return-on-Tangible-Equity too high?
GPT Healthcare's current Return-on-Tangible-Equity of 21.66% is near median its 10-year median of 22.82. Over the past 10 years, this metric has ranged from a low of 15.76 to a high of 28.54. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.09. GPT Healthcare's value of 21.66% is 114.8% above this industry median. Based on the distribution chart, GPT Healthcare ranks #217 out of 580 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, GPT Healthcare has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, GPT Healthcare ranks #217 out of 580 companies for Return-on-Tangible-Equity. This puts GPT Healthcare in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.09. GPT Healthcare's value of 21.66% is 114.8% above this benchmark. Historically, GPT Healthcare's own Return-on-Tangible-Equity has ranged from 15.76 to 28.54 over the past decade. While the company's 10-year median is 22.82 vs. the industry median of 10.09, GPT Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.09, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GPT Healthcare's current Return-on-Tangible-Equity of 21.66% is 114.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on GPT Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GPT Healthcare's current Return-on-Tangible-Equity is 21.66%, which is near median its own 10-year median of 22.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current Return-on-Tangible-Equity of 21.66%. The current Return-on-Tangible-Equity is 21.66%, which is near median its 10-year median of 22.82 and 114.8% above the Healthcare Providers & Services industry median of 10.09. GPT Healthcare's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current Return-on-Tangible-Equity is 21.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
44GF Score
Get the complete analysis for NSE:GPTHEALTH
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GPTHEALTH has been successfully added to your 
